This book provides a critical and comprehensive review of the methodologies available for
measuring drug adherence in clinical practice including those relying on emerging
technologies. The authors discuss the risk factors of non-adherence and shed light on how to
identify patients at risk of poor adherence. Drug therapies in chronic diseases rely heavily on
the patient's adherence since drugs that are not taken are ineffective and leave the patient
at high risk of developing clinical complications. Given the absence of new drugs for the
treatment of hypertension drug adherence is particularly important in these patients to
improve blood pressure control. The book further investigates a new aspect namely the
importance of drug adherence in clinical trials and studies and draws attention to the limits
of developing drugs without significant information on drug adherence. Several chapters are
dedicated to the importance of adherence in specific forms of hypertension such as resistant
hypertension dyslipidemia and hypertension associated with cardiovascular risk. As experts
confronted with drug adherence in their daily practice the authors analyse the real
effectiveness of several interventions aimed at improving drug adherence and put particular
emphasis on the importance of an interdisciplinary approach involving nurses and pharmacists.
The volume also includes a careful analysis of the health and economic impact of poor
adherence. The book is aimed at physicians pharmacists students and all health professionals
dealing not only with hypertension or dyslipidemia but also with chronic asymptomatic diseases
such as diabetes HIV or chronic respiratory diseases.
